ForSight VISION5

ForSight VISION5 was founded in 2010 as the fifth company created by ophthalmic product incubator ForSight Labs. ForSight VISION5 is developing non-invasive alternatives to eye drops, providing sustained treatment for major eye conditions including glaucoma, dry eye, and allergies. The company is currently conducting its second Phase II clinical study for its lead product, Helios.